Tiziana and Renaissance will partner to accelerate clinical development and potential commercial launch of nasal foralumab.

Alzheimer’s disease remains one of the most pressing medical mysteries of our time. Despite decades of research, scientists are still uncovering the complex mechanisms behind this ... Continue Reading ...

Tiziana Life Sciences (TLSA) announced that a nasal anti-CD3 preclinical study is nearing completion, and that foralumab could offer a novel ...

Tiziana Life Sciences ( ($TLSA) ) has shared an update. On February 25, 2025, Tiziana Life Sciences announced the nearing completion of a ...

NEW YORK, Feb. 25, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully hum ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Ivor Elrifi, CEO of Tiziana Life Sciences, commented, “Partnering with Renaissance is a significant milestone in our mission to bring intranasal foralumab to patients in need. Their proven track ...

Researchers at the University of Virginia have created the first comprehensive protein-level atlas of brain development, ...

Researchers have identified a key role microglia play in melanoma brain metastases progression and mechanisms to target them.

A new study published in Advanced Science has revealed how curcumin, a bioactive compound found in Curcuma aromatica (Yujin), ...

Microglia play a crucial role in neuroinflammation after ischemic brain injury. Previous data have shown that leukocyte immunoglobulin-like receptor B4 (LILRB4) was upregulated in mice after middle ...

Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers at the Institute for Neurosciences (IN), a joint center of the Spanish ...